Summit Therapeutics Inc. Business Finance Contracts & Agreements
17 Contracts & Agreements
- Exchange Agreements (1 contract)
- Note Agreements (7)
- Purchase Agreements (5)
- Registration Rights Agreements (2)
- Subscription Agreements (2)
- Form of Registration Rights Agreement (Filed With SEC on September 12, 2024)
- Form of Securities Purchase Agreement (Filed With SEC on September 12, 2024)
- Amended and Restated Promissory Note, dated February 17, 2024, by and (Filed With SEC on February 20, 2024)
- Securities Purchase Agreement, dated October 13, 2023, by and between Summit Therapeutics, Inc. and Manmeet Soni (Filed With SEC on November 7, 2023)
- Form of Subscription Rights Certificate (Filed With SEC on July 18, 2022)
- Promissory Note, dated March 10, 2022, issued by Summit Therapeutics Inc. in the name of Robert W. Duggan (Filed With SEC on March 11, 2022)
- Note Purchase Agreement, dated March 10, 2022, by and between Summit Therapeutics Inc. and Robert W. Duggan (Filed With SEC on March 11, 2022)
- Promissory Note, dated April 20, 2021, issued by Summit Therapeutics Inc. in the name of Robert W. Duggan (Filed With SEC on April 21, 2021)
- Note Purchase Agreement, dated April 20, 2021, by and between Summit Therapeutics Inc. and Robert W. Duggan (Filed With SEC on April 21, 2021)
- Form of Subscription Rights Certificate (Filed With SEC on April 21, 2021)
- Promissory Note, dated March 24, 2021, issued by Summit Therapeutics Inc. in the name of Robert W. Duggan (Filed With SEC on March 26, 2021)
- Note Purchase Agreement, dated March 24, 2021, by and between Summit Therapeutics Inc. and Robert W. Duggan (Filed With SEC on March 26, 2021)
- Securities Purchase Agreement, dated October 2, 2020, by and between Summit Therapeutics Inc. and Robert W. Duggan (incorporated by reference to Exhibit 10.1 to the Companys... (Filed With SEC on November 6, 2020)
- Registration Rights Agreement, dated November 6, 2020, by and between Summit Therapeutics Inc., Polar Capital Funds plc Biotechnology Fund and Mahkam Zanganeh Revocable Trust (Filed With SEC on November 6, 2020)
- Securities Purchase Agreement, dated November 6, 2020, by and between Summit Therapeutics Inc. and Mahkam Zanganeh Revocable Trust (Filed With SEC on November 6, 2020)
- Securities Purchase Agreement, dated November 6, 2020, by and between Summit Therapeutics Inc. and Polar Capital Funds plc Biotechnology Fund (Filed With SEC on November 6, 2020)
- Securities Purchase Agreement, dated October 2, 2020, by and between Summit Therapeutics Inc. and Robert W. Duggan (Filed With SEC on October 5, 2020)
